Tim-3 pathway controls regulatory and effector T Cell balance during hepatitis C virus infection

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 755-766

  Moorman, Jonathan P ^a,b   Wang, Jia M ^b,c   Zhang, Ying ^b,d   Ji, Xiao J ^b,e   Ma, Cheng J ^b   Wu, Xiao Y ^b   Jia, Zhan S ^d   Wang, Ke S ^f   Yao, Zhi Q ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b East Tennessee State University   (United States)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; KI 67 ANTIGEN; MUCIN; PROTEIN TIM 3; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION;

APOPTOSIS REGULATORY PROTEINS; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; PILOT PROJECTS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VIREMIA;

EID: 84863630845     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200162     Document Type: Article

References (50)

1. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5: 558-567. (Pubitemid 41196755)
2. Walker, C. M. 2010. Adaptive immunity to the hepatitis C virus. Adv. Virus Res. 78: 43-86.
3. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
4. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
5. Belkaid, Y., and W. Chen. 2010. Regulatory ripples. Nat. Immunol. 11: 1077-1078.
6. + T regulatory cell-mediated suppression. Immunity 30: 636-645.
7. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
8. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775. (Pubitemid 46279714)
9. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17: 279-288.
10. + regulatory T cell function. Eur. J. Immunol. 34: 2480-2488.
11. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7: 875-888. (Pubitemid 350006238)
12. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
13. Haiqi, H., Z. Yong, and L. Yi. 2011. Transcriptional regulation of Foxp3 in regulatory T cells. Immunobiology 216: 678-685.
14. Nishimura, H., and T. Honjo. 2001. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22: 265-268. (Pubitemid 32667515)
15. Hafler, D. A., and V. Kuchroo. 2008. TIMs: central regulators of immune responses. J. Exp. Med. 205: 2699-2701.
16. + HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120: 4546-4557.
17. Vali, B., R. B. Jones, A. Sakhdari, P. M. Sheth, K. Clayton, F. Y. Yue, G. Gyenes, D. Wong, M. B. Klein, S. Saeed, et al. 2010. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur. J. Immunol. 40: 2493-2505.
18. Ni, L., C. J. Ma, Y. Zhang, S. Nandakumar, C. L. Zhang, X. Y. Wu, T. Borthwick, A. Hamati, X. Y. Chen, U. Kumaraguru, et al. 2011. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunol. Cell Biol. 89: 535-539.
19. + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119: 551-564.
20. Mengshol, J. A., L. Golden-Mason, T. Arikawa, M. Smith, T. Niki, R. McWilliams, J. A. Randall, R. McMahan, M. A. Zimmerman, M. Rangachari, et al. 2010. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5: e9504.
21. Bullwinkel, J., B. Baron-Lühr, A. Lüdemann, C. Wohlenberg, J. Gerdes, and T. Scholzen. 2006. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J. Cell. Physiol. 206: 624-635. (Pubitemid 43191037)
22. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106: 1239-1249.
23. Yao, Z. Q., D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167: 5264-5272. (Pubitemid 33009764)
24. Yao, Z. Q., S. Ray, A. Eisen-Vandervelde, S. Waggoner, and Y. S. Hahn. 2001. Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol. 14: 277-295. (Pubitemid 34309058)
25. Yao, Z. Q., A. Eisen-Vandervelde, S. Ray, and Y. S. Hahn. 2003. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 314: 271-282. (Pubitemid 37153316)
26. + T cells leads to impaired activation of Lck and Akt. J. Virol. 78: 6409-6419.
27. Yao, Z. Q., E. King, D. Prayther, D. Yin, and J. Moorman. 2007. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol. 20: 276-287. (Pubitemid 47076209)
28. Frazier, A. D., C. L. Zhang, L. Ni, C. J. Ma, Y. Zhang, X. Y. Wu, A. N. Atia, Z. Q. Yao, and J. P. Moorman. 2010. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection. Viral Immunol. 23: 487-495.
29. Yao, Z. Q., D. Prayther, C. Trabue, Z. P. Dong, and J. Moorman. 2008. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein. Immunology 125: 197-207.
30. Yao, Z. Q., L. Ni, Y. Zhang, C. J. Ma, C. L. Zhang, Z. P. Dong, A. D. Frazier, X. Y. Wu, P. Thayer, T. Borthwick, et al. 2011. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma. Immunol. Invest. 40: 243-264.
31. + T cell responses. Vaccine 29: 3169-3176.
32. Ma, C. J., L. Ni, Y. Zhang, C. L. Zhang, X. Y. Wu, A. N. Atia, P. Thayer, J. P. Moorman, and Z. Q. Yao. 2011. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology 132: 421-431.
33. Zhang, Y., C. J. Ma, L. Ni, X. Y. Wu, A. N. Atia, P. Thayer, U. Shanker, C. F. Li, J. P. Moorman, and Z. Q. Yao. 2011. Crosstalk between PD-1 and SOCS-1 in HCV core-mediated IL-12 suppression. J. Immunol. 186: 3093-3103.
34. Zhang, Y., C. J. Ma, X. Y. Wu, J. P. Moorman, and Z. Q. Yao. 2011. A crucial role for Tim-3 in negative regulation of monocyte IL-12 production in chronic hepatitis C infection. PLoS ONE 6: e19664.
35. + Monocytes. J. Leukoc. Biol. 91: 189-196.
36. Lee, J., J. M. Oh, J. W. Hwang, J. K. Ahn, E. K. Bae, J. Won, E. M. Koh, and H. S. Cha. 2011. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis. Scand. J. Rheumatol. 40: 334-340.
37. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182: 3191-3201.
38. Leroy, V., M. Bourliere, M. Durand, A. Abergel, A. Tran, M. Baud, D. Botta-Fridlund, A. Gerolami, D. Ouzan, P. Halfon, and J. P. Zarski. 2002. The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study. Eur. J. Gastroenterol. Hepatol. 14: 485-489. (Pubitemid 34518179)
39. Wiedmann, M., U. G. Liebert, U. Oesen, H. Porst, M. Wiese, S. Schroeder, U. Halm, J. Mössner, and F. Berr. 2000. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 31: 230-234. (Pubitemid 30033712)
40. Kramer, E. S., C. Hofmann, P. G. Smith, M. L. Shiffman, and R. K. Sterling. 2009. Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis. Dig. Dis. Sci. 54: 2016-2025.
41. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174: 1783-1786.
42. + T cell-dependent liver damage. J. Immunol. 176: 6235-6244.
43. + T cells by HCV core induces T cell-dependent hepatic inflammation. J. Leukoc. Biol. 78: 412-425.
44. Cottrez, F., and H. Groux. 2001. Regulation of TGF-β response during T cell activation is modulated by IL-10. J. Immunol. 167: 773-778. (Pubitemid 32660831)
45. Tarantino, G., A. Coppola, P. Conca, E. Cimino, and G. Di Minno. 2008. Can serum TGF-β1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? Int. J. Immunopathol. Pharmacol. 21: 1007-1012.
46. Marek, B., D. Kajdaniuk, U. Mazurek, E. Janczewska-Kazek, B. Kos-Kudla, B. Strzalka, A. Fila, D. Niedziolka, M. Beniowski, Z. Ostrowska, et al. 2005. TGF-β1 mRNA expression in liver biopsy specimens and TGF-β1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. J. Clin. Pharm. Ther. 30: 271-277. (Pubitemid 41603051)
47. + regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 35: 1336-1341.
48. + T cells. Nat. Immunol. 8: 1353-1362.
49. Anderson, A. C., G. M. Lord, V. Dardalhon, D. H. Lee, C. A. Sabatos-Peyton, L. H. Glimcher, and V. K. Kuchroo. 2010. T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur. J. Immunol. 40: 859-866.
50. Guo, M., X. Mao, Q. Ji, M. Lang, S. Li, Y. Peng, W. Zhou, B. Xiong, and Q. Zeng. 2010. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol. Cell Biol. 88: 555-564.